Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Clin Neuropharmacol ; 44(5): 169-174, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34238785

RESUMO

OBJECTIVES: Real-world data were used to describe first antiparkinsonian drug (FAPD) prescription patterns among Parkinson disease (PD) patients and to evaluate disease duration until levodopa (l-DOPA) treatment and until death, as related to FAPD, by age group. METHODS: The community-based cohort (2000-2012) included 6243 patients, members of an Israeli Health Maintenance Organizations. Time from FAPD purchase to 2 end points (l-DOPA purchase and death) was calculated. Cox regressions were used to estimate adjusted heart rate (HR) to either end point as related to FAPD type, by age group. RESULTS: During a mean follow-up of 4.8 ± 3.2 years, one third of the cohort died. The percent of l-DOPA use as a start drug increased with age, whereas the percent of dopamine agonists (DAs) and monoamine oxidase inhibitor B inhibitor (MAO-BI) decreased with age. Younger women were treated more often with DA as a start drug compared with younger men. In ages of younger than 50 years, time to l-DOPA start in the initial DA-group was 4 times longer than in the initial MAO-BI group (HR, 0.23; 95% confidence interval, 0.08-0.43; 1/0.23, 4.35). All age groups exhibited a similar survival time trend associated with initial drug type. An age-pooled HR with initial l-DOPA-group as a reference group yielded that survival time was 2.4 times longer for the initial DA group (HR, 0.41; 95% confidence interval, 0.31-0.55; 1/0.41, 2.44), 1.9 times and 1.4 times for initial MAO-BI or amantadine, respectively. CONCLUSIONS: First antiparkinsonian drug choice might be associated with time until l-DOPA initiation but may represent disease severity at the time of prescription, thus also affecting survival time as well. Real-world data illustrated that this choice is also age and sex dependent.


Assuntos
Doença de Parkinson , Antiparkinsonianos/uso terapêutico , Estudos de Coortes , Feminino , Sistemas Pré-Pagos de Saúde , Humanos , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/tratamento farmacológico
2.
J Nurs Scholarsh ; 38(3): 219-24, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17044338

RESUMO

PURPOSE: To examine the rate of genetic testing, the characteristics of those who had these tests, and to examine the public's openness to the possibility of expanding nurses' roles in maternal-child health (MCH) clinics to include providing genetic information. DESIGN: The study was conducted in nine MCH clinics in the central district of Israel. All women attending the clinics during 1 week were requested to complete the questionnaire. The sample consisted of 361 participants. FINDINGS: A high rate of genetic testing (80.4%) was shown. Higher education, being secular, and native-born Israeli predicted testing performance. Half of the tested participants reported that they did not understand the test results and were interested in receiving explanations regarding these results. Forty-four percent of respondents were interested in receiving genetic information from an MCH nurse. CONCLUSIONS: A high rate of genetic testing performance was reported. The public reported lack of information regarding genetic tests and their results. An appropriate setting for providing this information is the maternal-child health clinics.


Assuntos
Atitude Frente a Saúde , Aconselhamento Genético/psicologia , Testes Genéticos/psicologia , Enfermagem Materno-Infantil/organização & administração , Papel do Profissional de Enfermagem , Diagnóstico Pré-Natal/psicologia , Adulto , Tomada de Decisões , Escolaridade , Emigração e Imigração , Feminino , Aconselhamento Genético/organização & administração , Testes Genéticos/organização & administração , Conhecimentos, Atitudes e Prática em Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Israel , Modelos Logísticos , Idade Materna , Pessoa de Meia-Idade , Pesquisa Metodológica em Enfermagem , Educação de Pacientes como Assunto/organização & administração , Diagnóstico Pré-Natal/enfermagem , Diagnóstico Pré-Natal/estatística & dados numéricos , Autonomia Profissional , Encaminhamento e Consulta/organização & administração , Características de Residência , Inquéritos e Questionários
3.
Scand J Work Environ Health ; 31(1): 65-74, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15751621

RESUMO

OBJECTIVES: Dust and wheat-allergen exposure were assessed among bakers, flour millers, and bakery-ingredient producers, and the risk for sensitization was studied. METHODS: About 520 inhalable dust and wheat-allergen measurements were made among 270 Dutch workers. Data on sensitization to wheat and common allergens (atopy) were also available. Exposure was estimated according to the sector of industry, job title, and tasks. The shape of the relationship between sensitization and exposure was studied using a two-stage modeling approach: semi-parametric generalized additive modeling and, consequently, a simple description of the relationship using a parametric logistic model. To reduce the effect of exposure measurement errors (attenuation), a combination of the actual measured exposure and variance-weighted estimates of exposure was used. Results The effect of exposure to both inhalable dust and wheat allergens on sensitization was described best by a linear relationship in three industries and a quadratic relationship in one industry. The relation for the whole study population was best described as quadratic, and the probability of sensitization increased with exposure up to -2.7 mg/m3 for inhalable dust and approximately 25.7 microg EQ/m3 for wheat allergens. The risk decreased at higher exposures (P = 0.0121 and P = 0.0731 for dust and wheat, respectively). Atopy and sector of industry modified the sensitization risk significantly in all the analyses. Using a variant-weighted estimator to calculate exposures corrected for the bias and resulted in almost the same point risk estimators. Conclusions Exposure-response relationships for allergens may be nonlinear and differ between industries. A threshold is not indicated on which to base occupational exposure standards; alternatively, other approaches, such as benchmarking, seem warranted.


Assuntos
Alérgenos/efeitos adversos , Farinha/efeitos adversos , Manipulação de Alimentos , Doenças Profissionais/etiologia , Triticum/efeitos adversos , Hipersensibilidade a Trigo/etiologia , Poeira , Humanos , Exposição Ocupacional/efeitos adversos , Exposição Ocupacional/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA